Certificate of Analysis
HEMP QUALITY ASSURANCE TEST

Sample Name:

24181

Infused, Liquid Edible

Date Issued:

09/13/2024

Total THC 0.747 mg/mL
Total CBD 10.162 mg/mL
Sum Cannabinoids 11.722 mg/mL
Total Cannabinoids 11.718 mg/mL

Sample Information

Sample Details

Sample ID:240910Q016

Batch Number:

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Total THC: 0.747 mg/mL

Total CBD: 10.162 mg/mL

Sum of Cannabinoids: 11.722 mg/mL

Total Cannabinoids: 11.718 mg/mL

Density:0.8203 g/mL

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877))
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + Δ8-THC + CBL + CBN

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

Method: QSP 1157 - Analysis of Cannabinoids by HPLC-DAD

Summary

Total THC: 0.747 mg/mL

(Δ9-THC+0.877*THCa)

Total CBD: 10.162 mg/mL

(CBD+0.877*CBDa)

Total Cannabinoids: 11.718 mg/mL

Total CBG: 0.158 mg/mL

Total CBG (CBG+0.877*CBGa)

Total THCV: ND

Total THCV (THCV+0.877*THCVa)

Total CBC: 0.384 mg/mL

Total CBC (CBC+0.877*CBCa)

Total CBDV: 0.060 mg/mL

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

09/13/2024

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/mL)
Measurement
Uncertainty
(mg/mL)
Result
(mg/mL)
Result
(%)
Cannabidiol (CBD) 0.004 / 0.011 ±0.3780 10.134 1.2354
Δ9 Tetrahydrocannabinol (Δ9THC) 0.002 / 0.014 ±0.0410 0.747 0.0911
Cannabichromene (CBC) 0.003 / 0.010 ±0.0124 0.384 0.0468
Cannabinol (CBN) 0.001 / 0.007 ±0.0056 0.195 0.0238
Cannabigerol (CBG) 0.002 / 0.006 ±0.0077 0.158 0.0193
Cannabidivarin (CBDV) 0.002 / 0.012 ±0.0024 0.060 0.0073
Cannabidiolic Acid (CBDa) 0.001 / 0.026 ±0.0009 0.032 0.0039
Cannabicyclol (CBL) 0.003 / 0.010 ±0.0004 0.012 0.0015
Cannabichromenic Acid (CBCa) 0.001 / 0.015 N/A ND ND
Cannabigerolic Acid (CBGa) 0.002 / 0.007 N/A ND ND
Tetrahydrocannabivarin (THCV) 0.002 / 0.012 N/A ND ND
Tetrahydrocannabinolic Acid (THCa) 0.001 / 0.005 N/A ND ND
Cannabidivarinic Acid (CBDVa) 0.001 / 0.018 N/A ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.002 / 0.019 N/A ND ND
∆8 Tetrahydrocannabinol (Δ8THC) 0.01 / 0.02 N/A ND ND
SUM OF CANNABINOIDS 11.722 mg/mL 1.4290%
Density Test Result

0.8203 g/mL Tested 09/13/2024 Method: QSP 7870 - Sample Preparation

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.